CLSI EP23-A (R2018)
Laboratory Quality Control Based on Risk Management; Approved Guideline, EP23AE
standard by Clinical and Laboratory Standards Institute, 10/01/2011
Side Navigation
X
CLSI QMS03-A4
Training and Competence Assessment; Approved Guideline–Fourth Edition; QMS03Ed4E
standard by Clinical and Laboratory Standards Institute, 12/01/2016
CLSI QMS19
Customer Focus in a Quality Management System, 1st Edition, QMS19Ed1E
standard by Clinical and Laboratory Standards Institute, 09/01/2017
CLSI NBS04
Newborn Screening by Tandem Mass Spectrometry, NBS04Ed2E
standard by Clinical and Laboratory Standards Institute, 05/01/2017
CLSI QMS17
External Assessment, Audits, and Inspections of the Laboratory, 1st Edition, QMS17Ed1E
standard by Clinical and Laboratory Standards Institute, 08/01/2017
CLSI QMS14-A (R2018)
Quality Management System: Leadership and Management Roles and Responsibilities; Approved Guideling, QMS14AE
standard by Clinical and Laboratory Standards Institute, 12/01/2012
CLSI MM02A2
Immunoglobin and T-Cell Receptor Gene Rearrangement Assays; Approved Guideline, MM02-A2
standard by Clinical and Laboratory Standards Institute, 08/01/2002
CLSI EP07
Interference Testing in Clinical Chemistry; 3rd Edition, EP07Ed3E
standard by Clinical and Laboratory Standards Institute, 04/01/2018
CLSI M44-A2
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline–Second Edition, M44A2
standard by Clinical and Laboratory Standards Institute, 05/01/2009
CLSI NBS06-A
Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline, NBS06AE
standard by Clinical and Laboratory Standards Institute, 04/01/2013